Loading clinical trials...

CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery

Clinical Effectiveness of Continuous Blood Glucose Monitoring In Patients With Type 2 Diabetes Undergoing Orthopaedic Hip or Knee Replacement Surgery

NCT05666479•Stony Brook University

View on ClinicalTrials.gov

Summary

The purpose of this study is to analyze the efficacy and accuracy of real-time continuous glucose monitoring devices (rtCGM) in patients with Type 2 diabetes undergoing inpatient elective hip or knee surgery in the pre-, peri-, and post-operative setting at Stony Brook University Hospital (SBUH).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Greater than or equal to 18 years of age
•Scheduled for elective inpatient hip or knee replacement surgery at Stony Brook University Hospital (SBUH)
•Clinically diagnosed Type 2 Diabetes at least 6 months prior to surgery
•Literate and able to provide written informed consent
•Negative pregnancy test by serum or urine HCG at screening \[as documented in subject's medical record) for women of childbearing potential (WCBP)\]

Exclusion Criteria

•Less than 18 years of age
•Not scheduled for elective inpatient hip or knee replacement surgery at SBUH
•No clinical diagnosis of Type 2 diabetes at least 6 months prior to surgery
•Not literate or unable to provide written informed consent
•Documented diagnosis of organ failure
•Documented diagnosis of chronic infection
•Documented diagnosis of any active malignancy
•Documented diagnosis of hepatic (liver) dysfunction or cirrhosis
•Pregnant by serum or urine HCG at screening \[as documented in subject's medical record) for women of childbearing potential (WCBP)\]

Locations (1)

Stony Brook University

Stony Brook, New York, United States

Key Dates

Start Date

September 9, 2022

Primary Completion Date

April 30, 2024

Completion Date

September 1, 2024

Last Updated

April 19, 2024

Enrollment

ACTUAL participants

Conditions

Diabetes Mellitus, Type 2Arthroplasty, Replacement, HipArthroplasty, Replacement, Knee

Interventions

Dexcom G6 Pro Continuous Glucose Monitor (CGM)

DEVICE

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

NCT06959901

Obesity and Diabetes Mellitus, Type 2Diabetes Prevention

View study

RECRUITINGNA

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035

Diabetes Mellitus, Type 2Depressive Symptoms+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery

Inclusion Criteria

Exclusion Criteria

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes

Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use

Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes